Previous Page  13 / 22 Next Page
Information
Show Menu
Previous Page 13 / 22 Next Page
Page Background

Page 45

Notes:

conferenceseries

.com

Volume 5, Issue 3 (Suppl)

J Infect Dis Ther, an open access journal

ISSN:2332-0877

Infectious Diseases 2017

August 21-23, 2017

3

rd

Annual Congress on

Infectious Diseases

August 21-23, 2017 San Francisco, USA

In-house real time PCR for the diagnosis and prognostication of invasive fungal infections in a

tertiary care cancer hospital

Prashant Mule

Tata Memorial Hospital, India

Introduction:

Invasive fungal infections (IFI) have emerged as an important cause of morbidity and mortality in cancer

patients. Aggressive chemotherapeutic protocols for treatment resulting in prolonged and profound neutropenia, are the most

important contributory factors. Patients with hematological malignancies and those undergoing bone marrow transplantation

are at high risk of invasive mycoses and an increase in morbidity and mortality. Blood culture lacks the sensitivity but with the

availibility of molecular techniques, the diagnosis of systemic fungal infections has signifacantly improved.

Objectives:

To evaluate an in-house real-time PCR for the diagnosis of IFI. To correlate the results of PCR with the EORTC

classification of invasive fungal infections (IFI).

Methods:

3 ml of whole blood is collected from patients with suspected invasive fungal infections. Extraction is performed and

DNA is detected using SYBR green PCR. The panfungal PCR using primers NL1 and 260R targeting a region of the ribosomal

gene followed by species specific hybridization with probes for

Candida

species as well as

Aspergillus

species.

Results:

A total of 80 in patients were included in the study from August 2015 to December 2015 at Tata Memorial Hospital.

52 patients had haematological malignancies and 28 patients belonged to the surgical disease management group (DMG). They

were classified by the EORTC criteria as proven, possible and probable cases of IFI of the 80 patients, 49 were positive for yeast

DNA and 3 were positive for

Aspergillus

DNA.

Discussion:

Fungal infections, in neutropenic patients with malignancies do not show characteristic signs and symptoms,

making accurate diagnosis difficult. Early recognition is crucial, as the progression of invasive disease from detection to death

is typically less than 14 days. Empirical treatment with antifungal agents is initiated in high-risk patients with suspected fungal

infection. This is associated with high toxicity and high cost.

Conclusions:

The SYBR green real time PCR was useful and sensitive indicator for the detection of fungal DNA. The SYBR

Green PCR is found to be a reproducile assay and it is validated for patients with Candidemia.

Biography

Prashant Mule has completed his MD in Microbiology from the Department of Microbiology, Tata Memorial Hospital, Mumbai, India in 2016. Presently, he is working

as a Senior Resident in the Department of Microbiology. His areas of interests are Mycology, Molecular Microbiology, Virology and prevention of health care

associated infections. He has worked on the evaluation of in house real time PCR for the diagnosis and prognostication of invasive fungal infections in a tertiary

care cancer institute in Mumbai.

prashant.mule88@gmail.com

Prashant Mule, J Infect Dis Ther 2017, 5:3 (Suppl)

DOI: 10.4172/2332-0877-C1-026